---
title: "CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -1.09"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253649060.md"
datetime: "2025-08-19T12:58:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253649060.md)
  - [en](https://longbridge.com/en/news/253649060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253649060.md)
generator: "portal-rs"
---

# CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -1.09

EPS: As of FY2025 Q2, the actual value is USD -1.09.

EBIT: As of FY2025 Q2, the actual value is USD -4.789 M.

### Segment Revenue

-   **Research and Development Expenses**: Total R&D expenses were $2.7 million for the three months ended June 30, 2025, an increase of $0.8 million or 43.6% from the three months ended June 30, 2024.

### Operational Metrics

-   **Operating Loss**: Operating loss was $4.7 million for the three months ended June 30, 2025, compared to $3.2 million for the same period in 2024, representing an increase of 45.0%.
-   **Net Loss**: Net loss was $4.8 million for the three months ended June 30, 2025, compared to $3.2 million for the same period in 2024, representing an increase of 49.2%.

### Cash Flow

-   **Net Cash Used in Operating Activities**: Net cash used in operating activities was $9.5 million for the six months ended June 30, 2025, compared to $10.5 million for the same period in 2024.

### Unique Metrics

-   **Clinical Operations Costs**: Clinical operations costs increased due to close-out and analytical activities required for NDA submission related to two Phase 3 studies for CTx-1301.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to advance commercialization efforts for CTx-1301 into early 2026, requiring approximately $1.5 million of additional capital.
-   **Non-Core Business**: The company is evaluating strategic transactions to acquire or in-license additional products and product candidates to augment its internal development pipeline.

### Related Stocks

- [CINGW.US](https://longbridge.com/en/quote/CINGW.US.md)

## Related News & Research

- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Nvidia Earnings: Wall Street Expects Growth to Slow in Q2 — Dan Niles Says Hyperscalers Are Spending Like Never Before](https://longbridge.com/en/news/296822352.md)
- [There’s More to Consider, Says Investor About Sandisk Stock](https://longbridge.com/en/news/296795615.md)
- [AMD or Nvidia: Load Up on One AI Chip Stock, but Avoid the Other, Says Investor](https://longbridge.com/en/news/296792383.md)
- [Micron Sees 'No End' to AI Memory Supply Crunch: CEO Sanjay Mehrotra Says 'Nothing Ever Goes in a Straight Line'](https://longbridge.com/en/news/296743524.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**